Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.300
+0.010 (0.78%)
Nov 20, 2024, 4:00 PM EST - Market closed
Trinity Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 59.13 | 56.83 | 62.52 | 81.15 | 101.98 | 90.44 | Upgrade
|
| Revenue Growth (YoY) | -17.18% | -9.10% | -22.96% | -20.43% | 12.77% | -6.80% | Upgrade
|
| Cost of Revenue | 38 | 37.38 | 45.25 | 47.7 | 53.4 | 52.32 | Upgrade
|
| Gross Profit | 21.13 | 19.45 | 17.27 | 33.45 | 48.58 | 38.12 | Upgrade
|
| Selling, General & Admin | 27.38 | 31.15 | 26.98 | 22.5 | 25.07 | 32.7 | Upgrade
|
| Research & Development | 4.21 | 4.38 | 4.14 | 4.5 | 5.08 | 5.33 | Upgrade
|
| Other Operating Expenses | 0.1 | -0 | -0.34 | -0 | -0.02 | -0.09 | Upgrade
|
| Operating Expenses | 31.68 | 35.53 | 30.78 | 27 | 30.13 | 37.94 | Upgrade
|
| Operating Income | -10.55 | -16.08 | -13.51 | 6.46 | 18.45 | 0.18 | Upgrade
|
| Interest Expense | -7.57 | -10.15 | -11.53 | -7.09 | -5.54 | -6.58 | Upgrade
|
| Interest & Investment Income | - | - | - | 0 | 0.04 | 0.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.47 | 1.17 | 0.23 | 1.22 | -1.22 | 0.23 | Upgrade
|
| EBT Excluding Unusual Items | -16.65 | -25.06 | -24.81 | 0.6 | 11.73 | -5.7 | Upgrade
|
| Merger & Restructuring Charges | -2.28 | - | - | - | -2.43 | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -3.85 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.5 | -1.5 | - | - | - | - | Upgrade
|
| Asset Writedown | 0.76 | -9.61 | -5.36 | -2.51 | -17.22 | -22.92 | Upgrade
|
| Other Unusual Items | -0.77 | -0.77 | -13.61 | 3.84 | 1.28 | -1.38 | Upgrade
|
| Pretax Income | -20.43 | -36.93 | -43.78 | -1.92 | -6.63 | -30 | Upgrade
|
| Income Tax Expense | -0.1 | -0.06 | -0.19 | -0.07 | -0.62 | -1.01 | Upgrade
|
| Earnings From Continuing Operations | -20.33 | -36.87 | -43.59 | -1.85 | -6.01 | -28.99 | Upgrade
|
| Earnings From Discontinued Operations | -0 | 12.85 | 2.58 | 2.73 | -0.38 | 0.08 | Upgrade
|
| Net Income | -20.33 | -24.02 | -41.01 | 0.88 | -6.39 | -28.91 | Upgrade
|
| Net Income to Common | -20.33 | -24.02 | -41.01 | 0.88 | -6.39 | -28.91 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 8 | 7 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 8 | 7 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 23.79% | 13.46% | 61.40% | - | - | -0.01% | Upgrade
|
| EPS (Basic) | -2.15 | -3.14 | -6.08 | 0.21 | -1.53 | -6.92 | Upgrade
|
| EPS (Diluted) | -2.15 | -3.14 | -6.08 | 0.21 | -1.53 | -6.98 | Upgrade
|
| Free Cash Flow | -7.8 | -12.36 | -2.02 | 11.43 | 20.55 | 3.28 | Upgrade
|
| Free Cash Flow Per Share | -0.82 | -1.61 | -0.30 | 2.73 | 4.92 | 0.79 | Upgrade
|
| Gross Margin | 35.74% | 34.22% | 27.62% | 41.23% | 47.64% | 42.15% | Upgrade
|
| Operating Margin | -17.84% | -28.29% | -21.61% | 7.96% | 18.09% | 0.20% | Upgrade
|
| Profit Margin | -34.39% | -42.26% | -65.59% | 1.08% | -6.26% | -31.97% | Upgrade
|
| Free Cash Flow Margin | -13.19% | -21.75% | -3.23% | 14.08% | 20.15% | 3.63% | Upgrade
|
| EBITDA | -8.65 | -14.3 | -11.22 | 9.18 | 21.52 | 5.08 | Upgrade
|
| EBITDA Margin | -14.63% | -25.17% | -17.94% | 11.31% | 21.11% | 5.61% | Upgrade
|
| D&A For EBITDA | 1.9 | 1.78 | 2.29 | 2.72 | 3.08 | 4.89 | Upgrade
|
| EBIT | -10.55 | -16.08 | -13.51 | 6.46 | 18.45 | 0.18 | Upgrade
|
| EBIT Margin | -17.84% | -28.29% | -21.61% | 7.96% | 18.09% | 0.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.